URSA-QUALITY-SPC1: Statin Therapy for ASCVD Patients (SPC1)
  • 17 Dec 2024
  • 1 Minute to read
  • Dark
    Light

URSA-QUALITY-SPC1: Statin Therapy for ASCVD Patients (SPC1)

  • Dark
    Light

Article summary

Measure Description

Among patients with atherosclerotic cardiovascular disease, the percentage with any dispensed moderate- or high-intensity statin in the prior 12 months. Unadjusted Certified Measure c22c23d3-e057-4e7a-8685-e21ad66d8112

Metadata

  • Measure Type: Rate Measure
  • Temporal Structure: Entity
  • Component Class: Long-Form
  • Denominator Case Field: Patient ID, Output NCQA Payer Type Code
  • Target Direction: Up

Denominator Description

Patients with atherosclerotic cardiovascular disease.

Numerator Description

One per qualifying denominator patient with documentation of a moderate- or high-intensity statin dispensed in the prior 12 months.

NCQA MY2024

*HEDISĀ® is a registered trademark of the National Committee for Quality Assurance


Was this article helpful?